Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY: ZBH )

100.52 +0.61 (+0.61%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 Next >
Where Zimmer Biomet Holdings Stands With Analysts
Via Benzinga
7 Healthcare Stocks to invest in for a Healthy Future
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners. 
Via InvestorPlace
Is the Ozempic-Driven DexCom Selloff Overdone?
Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly? 
Via MarketBeat
7 High-Growth S&P 500 Stocks to Buy Now
Although industry stalwarts don’t typically offer robust profitability potential, these high-growth S&P 500 stocks might change your tune. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Analyst Ratings for Zimmer Biomet Holdings
Via Benzinga
Peering Into Zimmer Biomet Holdings's Recent Short Interest
Via Benzinga
A Look Into Zimmer Biomet Holdings Inc's Price Over Earnings
Via Benzinga
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth. 
Via MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar
Dexcom says the popularity of GLP-1 drugs won't hurt its continuous glucose monitors. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
Analyst Expectations for Zimmer Biomet Holdings's Future
Via Benzinga
How Is The Market Feeling About Zimmer Biomet Holdings?
Via Benzinga
Cramer Gives Auto Semiconductor Company A Thumbs Down: 'Self-Driving Has Hit A Snag'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Extreme Networks, Inc. (NASDAQ: EXTR) is fine. 
Via Benzinga
Stryker, NextEra Energy And A Stock Down 18% In Past Month: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Josh Brown of Ritholtz Wealth Management said he is sticking with NextEra Energy, Inc. (NYSE: NEE) 
Via Benzinga
3M Deepens Bench, Fills CEO, CFO And Other C-Suite Positions At Healthcare Spinoff
3M Co (NYSE: MMM) set several leadership positions for its independent healthcare company  
Via Benzinga
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
Via InvestorPlace
Zimmer Biomet Clocks 5% Revenue Growth In Q2, Raises Annual Guidance
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) reported Q2 FY23 adjusted EPS of $1.82,  
Via Benzinga
A Look Into Zimmer Biomet Holdings' Debt
Via Benzinga
Expert Ratings for Zimmer Biomet Holdings
Via Benzinga
Looking Into Zimmer Biomet Holdings's Recent Short Interest
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Jim Cramer Says Sell Activision And 'Roll' Your Profits Into This 'Incredibly Cheap' Video Game Company
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Zimmer Biomet Holdings, Inc. (NYSE: ZBH). 
Via Benzinga
Where Zimmer Biomet Holdings Stands With Analysts
Via Benzinga
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
Zimmer Biomet, InMode And The World's Largest Investment Firm: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephanie Link of Hightower said Zimmer Biomet Holdings, Inc. 
Via Benzinga
UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout
UNH stock slumped after UnitedHealth said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock soaring. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.